vs
Side-by-side financial comparison of First Western Financial Inc (MYFW) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $27.5M, roughly 1.7× First Western Financial Inc). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 10.0%).
The Western Union Company is an American multinational financial services corporation headquartered in Denver, Colorado.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
MYFW vs STEM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $27.5M | $47.1M |
| Net Profit | — | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | — | -17.7% |
| Net Margin | — | -33.9% |
| Revenue YoY | — | -15.6% |
| Net Profit YoY | — | 68.8% |
| EPS (diluted) | $0.63 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $27.5M | — | ||
| Q4 25 | $26.7M | $47.1M | ||
| Q3 25 | $26.3M | $38.2M | ||
| Q2 25 | $24.2M | $38.4M | ||
| Q1 25 | $24.8M | $32.5M | ||
| Q4 24 | $24.3M | $55.8M | ||
| Q3 24 | $22.5M | $29.3M | ||
| Q2 24 | $22.8M | $34.0M |
| Q1 26 | — | — | ||
| Q4 25 | $3.3M | $-16.0M | ||
| Q3 25 | $3.2M | $-23.8M | ||
| Q2 25 | $2.5M | $202.5M | ||
| Q1 25 | $4.2M | $-25.0M | ||
| Q4 24 | $2.7M | $-51.1M | ||
| Q3 24 | $2.1M | $-148.3M | ||
| Q2 24 | $1.1M | $-582.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% |
| Q1 26 | — | — | ||
| Q4 25 | 16.6% | -17.7% | ||
| Q3 25 | 15.1% | -33.6% | ||
| Q2 25 | 13.7% | -34.8% | ||
| Q1 25 | 21.6% | -65.0% | ||
| Q4 24 | 16.1% | -84.4% | ||
| Q3 24 | 11.9% | -493.2% | ||
| Q2 24 | 6.2% | -1705.5% |
| Q1 26 | — | — | ||
| Q4 25 | 12.9% | -33.9% | ||
| Q3 25 | 12.1% | -62.2% | ||
| Q2 25 | 10.3% | 527.8% | ||
| Q1 25 | 16.9% | -76.9% | ||
| Q4 24 | 11.3% | -91.6% | ||
| Q3 24 | 9.5% | -506.3% | ||
| Q2 24 | 4.7% | -1712.6% |
| Q1 26 | $0.63 | — | ||
| Q4 25 | $0.33 | $-4.40 | ||
| Q3 25 | $0.32 | $-2.84 | ||
| Q2 25 | $0.26 | $-1.79 | ||
| Q1 25 | $0.43 | $-0.15 | ||
| Q4 24 | $0.28 | $-15.29 | ||
| Q3 24 | $0.22 | $-18.24 | ||
| Q2 24 | $0.11 | $-71.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $273.4M | $-249.4M |
| Total Assets | $3.2B | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $48.9M | ||
| Q3 25 | — | $43.1M | ||
| Q2 25 | — | $40.8M | ||
| Q1 25 | — | $58.6M | ||
| Q4 24 | — | $56.3M | ||
| Q3 24 | — | $75.4M | ||
| Q2 24 | — | $89.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $273.4M | — | ||
| Q4 25 | $265.6M | $-249.4M | ||
| Q3 25 | $261.5M | $-235.7M | ||
| Q2 25 | $258.8M | $-214.1M | ||
| Q1 25 | $256.6M | $-417.5M | ||
| Q4 24 | $252.3M | $-398.4M | ||
| Q3 24 | $248.8M | $-344.1M | ||
| Q2 24 | $246.9M | $-203.2M |
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $308.9M | ||
| Q3 25 | $3.2B | $362.6M | ||
| Q2 25 | $3.0B | $379.2M | ||
| Q1 25 | $2.9B | $405.1M | ||
| Q4 24 | $2.9B | $437.4M | ||
| Q3 24 | $2.9B | $537.8M | ||
| Q2 24 | $2.9B | $691.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | $8.2M | ||
| Q3 25 | $10.0M | $11.4M | ||
| Q2 25 | $-9.1M | $-21.3M | ||
| Q1 25 | $8.0M | $8.5M | ||
| Q4 24 | $606.0K | $-14.7M | ||
| Q3 24 | $18.8M | $-9.4M | ||
| Q2 24 | $-11.5M | $-11.9M |
| Q1 26 | — | — | ||
| Q4 25 | $-5.8M | — | ||
| Q3 25 | $9.0M | — | ||
| Q2 25 | $-9.7M | — | ||
| Q1 25 | $7.0M | — | ||
| Q4 24 | $-607.0K | — | ||
| Q3 24 | $18.6M | — | ||
| Q2 24 | $-11.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | -21.6% | — | ||
| Q3 25 | 34.1% | — | ||
| Q2 25 | -39.9% | — | ||
| Q1 25 | 28.1% | — | ||
| Q4 24 | -2.5% | — | ||
| Q3 24 | 82.3% | — | ||
| Q2 24 | -52.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 14.9% | — | ||
| Q3 25 | 4.1% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 1.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | -0.54× | — | ||
| Q3 25 | 3.15× | — | ||
| Q2 25 | -3.63× | -0.11× | ||
| Q1 25 | 1.91× | — | ||
| Q4 24 | 0.22× | — | ||
| Q3 24 | 8.83× | — | ||
| Q2 24 | -10.68× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MYFW
| Net Interest Income | $20.9M | 76% |
| Noninterest Income | $6.7M | 24% |
STEM
Segment breakdown not available.
